Patrick Hemingway, American Writer, Wildlife Conservationist and Last Surviving Son of Nobel Prize Winner, Ernest Hemingway, 97, has passed
Hemingway, like his late father, was a global citizen and lifelong adventurer…
Manulife and UpLink Announce Winners of the ‘Innovating for Asia’s Demographic Future Challenge’
Challenge is second of three in a multiyear partnership to help shape…
Manulife Champions Longevity in Asia with Inaugural Symposium and Enhanced ManulifeMOVE
Over 1,000 attendees convened for the landmark event, graced by the presence…
Casio India brings its First-Ever Automatic watch to India with the Launch of EDIFICE EFK-100 series
~The legacy of Casio now transcends to the world of automatic timepieces,…
A New Era in Smart Living: ECOVACS Unveils DEEBOT X11 with PowerBoost Technology and Expands Service Robot Portfolio at IFA 2025
ECOVACS is introducing its groundbreaking robotic vacuum cleaner DEEBOT X11 at IFA…
ACKO Launches Support Initiative to Help Vehicle Owners Book HSRP Plates Before Maharashtra’s Extended Deadline
BENGALURU, India, Sept. 6, 2025 /PRNewswire/ -- The Maharashtra government has extended the…
Yutong Bus Link+ Empowers Fleets with Intelligent Management and Higher Operational Efficiency
ZHENGZHOU, China, Sept. 5, 2025 /PRNewswire/ -- Yutong Bus ("Yutong", SHA: 600066), a…
Altai Provides Update on Quebec Litigation
September 05, 2025 18:39 ET Â | Source: Altai Resources Inc. TORONTO, Sept.…
Enovix Announces Completion of Warrant Dividend Program
September 05, 2025 18:08 ET Â | Source: Enovix Corporation Warrants Expired and…
![U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease](https://i3.wp.com/mms.businesswire.com/media/20250905840795/en/1247790/22/Takeda_Red_Logo_2021.jpg?w=420&resize=420,280&ssl=1 "U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease"){kind=logo}
U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
− Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce…
